Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01888120 · ClinicalTrials.gov registry record
Patient Registry of Intrathecal Ziconotide Management(PRIZM)
A clinical trial, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- 93
- Enrollment target
NCT01888120 is a clinical trial that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 93 participants.
The verdict
NCT01888120 has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the effectiveness, long-term safety, tolerability, satisfaction with treatment, and health-related quality of life (HRQoL) associated with Intrathecal PRIALT use for severe chronic pain of varying etiologies.
Interventions
- DRUG Ziconotide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01888120
The ClinicalTrials.gov registry entry for NCT01888120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ziconotide is the first listed.
NCT01888120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01888120 about?
NCT01888120 is a clinical study titled "Patient Registry of Intrathecal Ziconotide Management(PRIZM)". The objectives of this study are to evaluate the effectiveness, long-term safety, tolerability, satisfaction with treatment, and health-related quality of life (HRQoL) associated with Intrathecal PRIALT use for severe chronic pain of varying etiologies.
What is the current status of trial NCT01888120?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2013-07. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01888120?
The interventions under investigation include: Ziconotide (DRUG).
Who is sponsoring clinical trial NCT01888120?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.